• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    BALAXI PHARMACEUTICALS LIMITED — Board Meeting, 05-08-2026: Outcome of Board Meeting

    05-08-2026 | 01:55 pm

    Balaxi Pharma's board approved Q1 financial results. Consolidated Revenue from Operations at ₹80.68 Cr, Net Profit at ₹1.30 Cr. Its Hyderabad pharma plant started commercial production with 2 products & secured approvals for 29 more, eyeing WHO-GMP certification.

    No comments yet. Be the first to comment!

    All announcements from BALAXI PHARMACEUTICALS LIMITED